Rubens Rd
Impact in
-
- Breast Cancer Treatment Studies
-
- Cancer Treatment and Pharmacology
- Bone health and treatments
- HER2/EGFR in Cancer Research
Papers in
- Oncology 6
- Cancer Treatment and Pharmacology 3
- Bone health and treatments 3
- Cancer Risks and Factors 1
- Co-authors
- Coleman Re (2 shared papers)IS Fentiman (1 shared paper)I. Fogelman (2 shared papers)MA Richards (1 shared paper)WM Gregory (1 shared paper)Dong‐Yu Wang (1 shared paper)T Bates (1 shared paper)
- Journals
- International Journal of Gynecology & Obstetrics (1 paper)PubMed (8 papers)
- Partner nations
- United Kingdom
In The Last Decade
Rubens Rd
8 papers receiving 113 citations
Peers
Comparison fields: 5 of 43
- Cancer Research 47
- Oncology 60
- Pulmonary and Respiratory Medicine 36
- Genetics 29
- Obstetrics and Gynecology 6
Countries citing papers authored by Rubens Rd
This map shows the geographic impact of Rubens Rd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rubens Rd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rubens Rd more than expected).
Fields of papers citing papers by Rubens Rd
This network shows the impact of papers produced by Rubens Rd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rubens Rd. The network helps show where Rubens Rd may publish in the future.
Co-authors
The 7 scholars most cited alongside Rubens Rd, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1992 | 35 | |
| 2 | Brain metastases from breast cancer: clinical course, prognosis and influence of treatment. | 1981 | 28 |
| 3 | A new combined approach to the conservative treatment of early breast cancer. | 1984 | 26 |
| 4 | Hypercalcaemia and breast cancer--an increased humoral component in patients with liver metastases. | 1988 | 14 |
| 5 | Trial of tamoxifen at a dose of 40 mg daily after disease progression during tamoxifen therapy at a dose of 20 mg daily. | 1982 | 13 |
| 6 | Relation between endocrine function and survival of patients with breast cancer after hypophysectomy. | 1979 | 5 |
| 7 | Improving treatment for advanced breast cancer. | 1993 | 4 |
| 8 | Comparison of 99Tcm-labelled MDP and DMAD bone scanning agents in patients with advanced breast cancer. | 1988 | 1 |
| 9 | Phase II trial of prednimustine as first-line chemotherapy in patients with advanced breast cancer. | 1987 | 1 |
About Rubens Rd
Rubens Rd is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Cancer Research and Organic Chemistry, having authored 9 papers that have together received 127 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (3 papers), Bone health and treatments (3 papers), Breast Cancer Treatment Studies (2 papers), Radiopharmaceutical Chemistry and Applications (2 papers), Bone and Joint Diseases (1 paper), Organometallic Complex Synthesis and Catalysis (1 paper), Estrogen and related hormone effects (1 paper) and Cancer Risks and Factors (1 paper). The work is most often cited by research in Cancer Research (47 citations), Oncology (60 citations), Pulmonary and Respiratory Medicine (36 citations), Genetics (29 citations) and Obstetrics and Gynecology (6 citations). Rubens Rd has collaborated with scholars based in United Kingdom. Frequent co-authors include Coleman Re, IS Fentiman, I. Fogelman, MA Richards, WM Gregory, Dong‐Yu Wang and T Bates. Their work appears in journals such as International Journal of Gynecology & Obstetrics and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.